1st Circ. Backs GSK's Preemption Win Against Zofran MDL

By Dorothy Atkins (January 9, 2023, 9:43 PM EST) -- The First Circuit affirmed on Monday GlaxoSmithKline's summary judgment win against hundreds of product liability lawsuits in multidistrict litigation alleging GSK failed to warn consumers that the anti-nausea drug Zofran might cause birth defects, finding that new animal studies don't support the consumers' birth defect claims....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!